Ruth Greferath
Nessuna posizione attualmente
Storia della carriera di Ruth Greferath
Precedenti posizioni note di Ruth Greferath
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AC IMMUNE SA | Fondatore | 13/02/2003 | - |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Fondatore | 03/08/2009 | - |
| Corporate Officer/Principal | 31/07/2009 | - |
Formazione di Ruth Greferath
| Yeshiva University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Svizzera | 2 |
Posizioni
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Aziende private | 1 |
|---|---|
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
- Borsa valori
- Insiders
- Ruth Greferath
- Esperienza
